BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34469597)

  • 1. Cumulative menstrual months and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities Study.
    Cole SE; John EM; Hines LM; Phipps AI; Koo J; Ingles SA; Baumgartner KB; Slattery ML; McKean-Cowden R; Wu AH
    Int J Cancer; 2022 Jan; 150(2):208-220. PubMed ID: 34469597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study.
    John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM
    Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities study.
    John EM; Phipps AI; Hines LM; Koo J; Ingles SA; Baumgartner KB; Slattery ML; Wu AH
    Int J Cancer; 2020 Oct; 147(7):1808-1822. PubMed ID: 32064598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: The multiethnic cohort study.
    Sarink D; White KK; Loo LWM; Wu AH; Wilkens LR; Le Marchand L; Park SY; Setiawan VW; Merritt MA
    Int J Cancer; 2022 Jan; 150(2):221-231. PubMed ID: 34486728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
    Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
    Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study.
    John EM; Sangaramoorthy M; Phipps AI; Koo J; Horn-Ross PL
    Am J Epidemiol; 2011 Jan; 173(2):201-16. PubMed ID: 21084558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses' Health Studies.
    Fortner RT; Brantley KD; Tworoger SS; Tamimi RM; Rosner B; Holmes MD; Willett WC; Eliassen AH
    Breast Cancer Res Treat; 2024 Jul; 206(1):77-90. PubMed ID: 38592542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
    Ma H; Ursin G; Xu X; Lee E; Togawa K; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Lu Y; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
    Breast Cancer Res; 2018 Jan; 20(1):5. PubMed ID: 29357906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women.
    Gong Z; Ambrosone CB; McCann SE; Zirpoli G; Chandran U; Hong CC; Bovbjerg DH; Jandorf L; Ciupak G; Pawlish K; Lu Q; Hwang H; Khoury T; Wiam B; Bandera EV
    Int J Cancer; 2014 Mar; 134(6):1422-35. PubMed ID: 23996837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status.
    Baglia ML; Zheng W; Li H; Yang G; Gao J; Gao YT; Shu XO
    Int J Cancer; 2016 Aug; 139(4):742-8. PubMed ID: 27038352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.
    John EM; McGuire V; Kurian AW; Koo J; Shariff-Marco S; Gomez SL; Cheng I; Keegan THM; Kwan ML; Bernstein L; Vigen C; Wu AH
    Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):351-363. PubMed ID: 33355191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in China.
    Li J; Huang Y; Zhang BN; Fan JH; Huang R; Zhang P; Wang SL; Zheng S; Zhang B; Yang HJ; Xie XM; Tang ZH; Li H; He JJ; Hsieh E; Qiao YL; Li JY
    PLoS One; 2014; 9(1):e87224. PubMed ID: 24489874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity.
    Nagrani R; Mhatre S; Rajaraman P; Soerjomataram I; Boffetta P; Gupta S; Parmar V; Badwe R; Dikshit R
    Eur J Cancer; 2016 Oct; 66():153-61. PubMed ID: 27573429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer.
    Bessonova L; Taylor TH; Mehta RS; Zell JA; Anton-Culver H
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):389-96. PubMed ID: 21217087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium.
    Chollet-Hinton L; Olshan AF; Nichols HB; Anders CK; Lund JL; Allott EH; Bethea TN; Hong CC; Cohen SM; Khoury T; Zirpoli GR; Borges VF; Rosenberg LA; Bandera EV; Ambrosone CB; Palmer JR; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1722-1729. PubMed ID: 28903991
    [No Abstract]   [Full Text] [Related]  

  • 19. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
    Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
    Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic long-term exposure to cadmium air pollution and breast cancer risk in the French E3N cohort.
    Amadou A; Praud D; Coudon T; Danjou AMN; Faure E; Leffondré K; Le Romancer M; Severi G; Salizzoni P; Mancini FR; Fervers B
    Int J Cancer; 2020 Jan; 146(2):341-351. PubMed ID: 30851122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.